Skip to content

Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF)

Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF): a Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07213245
Enrollment
24
Registered
2025-10-08
Start date
2025-12-01
Completion date
2026-12-31
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appetite, Obesity and Obesity-related Medical Conditions

Brief summary

The overall aim of this project is to study the effects of short-term high ultra-processed food intake, compared to nutrient- and energy density matched low ultra-processed food (UPF) intake, on energy intake and appetite. A total of 24 men and women who meet all inclusion criteria and none of the exclusion criteria will be invited to participate. A randomized 2\*2 factorial four-way crossover study will be conducted at the Department of Internal medicine and Clinical Nutrition at the University of Gothenburg, comparing a high-UPF meal to a low-UPF meal also with high and/or low energy density. A supervised breakfast meal will be served, and postprandial blood samples and appetite measures will be collected continuously up to 4 hours after the breakfast meal. Subsequently, an ad libitum lunch meal will be served, and energy intake will be recorded.

Interventions

Meal high in energy density, high in ultra-processed food

Meal high in energy density, low in ultra-processed food

Meal low in energy density, high in ultra-processed food

Meal low in energy density, low in ultra-processed food

Sponsors

Göteborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Intervention model description

Factorial assignment 2X2 factorial

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index (BMI) 18.5-30 kg/m2 * Fasting glucose \< 6.1 mmol/l * Hb \>110 g/L * Weight stability the last 3 months +/-5%

Exclusion criteria

* Food allergies, intolerances or preferences preventing consumption of any products included in the study. * Unable to sufficiently understand written and spoken Swedish or English to provide written consent and understand information and instructions from the study personal. * Pregnant, lactating or planning a pregnancy during the study period. * Blood donation or participation in a clinical study with blood sampling within 30 days prior to screening visit and throughout the study. * History of gastrointestinal conditions or major gastrointestinal surgery (Inflammatory bowel disease, Crohn's disease, malabsorption, colostomy, bowel resection, gastric bypass surgery etc.). * Type 1 diabetes or type 2 diabetes. * Thyroid disorder. * Current smoking, vaping. * Following any weight reduction program or having followed one during the last 6 months prior to screening. * Not habitually eating breakfast (\<5 times/week). * Restrained eating based on the three-factor eating questionnaire.

Design outcomes

Primary

MeasureTime frameDescription
Gastrointestinal hormones - peptide YYBaseline to 4 hours after test mealDifference between groups in peptide YY (PYY) in response to meal
Gastrointestinal hormones - ghrelinBaseline to 4 hours after test mealDifference between groups in ghrelin in response to meal
Gastrointestinal hormones - cholecystokininBaseline to 4 hours after test mealDifference between groups in cholecystokinin in response to meal
Gastrointestinal hormones - incretinsBaseline to 4 hours after test mealDifference between groups in incretins GIP and GLP-1 in response to meal
Self-reported appetiteBaseline to 8 hours after test mealAppetite ratings (hunger, fullness, and desire to eat) will be assessed using separate 100-mm Visual Analogue Scales (VAS), anchored with "not at all" (0 mm) and "extremely" (100 mm). Higher scores indicate greater perceived intensity.
Energy intake4 hours after test mealEnergy intake estimated by nutrient calculation of leftover food at the ad libitum lunch meal

Secondary

MeasureTime frameDescription
Inflammatory markers in blood - lipopolysaccharidesBaseline to 4 hours after test mealDifferences between groups in immunological responses (lipopolysaccharides) in response to meal.
Inflammatory markers in blood - GlycABaseline to 4 hours after test mealDifferences between groups in immunological responses (GlycA) in response to meal.
Insulin postprandialBaseline to 4 hours after test mealDifference between groups in postprandial insulin in response to meal.
Eating rateBaseline til end of study mealTime it takes to eat the study meal until satisfied
Glucose postprandialBaseline to 4 hours after test mealDifference between groups in postprandial glucose in response to meal.
Lipid profileBaseline to 4 hours after test mealDifferences between groups in lipid profile (plasma) measured using lipidomics in response to meals.
Lipid metabolismBaseline to 4 hours after test mealDifference between groups in postprandial lipid metabolism in response to meal.
MetabolomeBaseline to 4 hours after test mealDifferences between groups in metabolome (plasma) measured using metabolomics in response to meals.
ProteomeBaseline to 4 hours after test mealDifferences between groups in proteome (plasma) measured using proteomics in response to meals.
Self-reported prospective energy intakeFrom 30 min until midnight or bedtime (which ever comes first)Self-reported prospective energy intake during the remainder of the day
Inflammatory markers in blood - cytokinesBaseline to 4 hours after test mealDifferences between groups in immunological responses (cytokines) in response to meal.

Countries

Sweden

Contacts

CONTACTTherese Karlsson, PhD
therese.karlsson@gu.se+46704089150
CONTACTLinnea Bärebring, PhD
linnea.barebring@gu.se
PRINCIPAL_INVESTIGATORTherese Karlsson, PhD

University of Gothenburg, Institute of medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026